Press Releases

Date	Title	Company
17-Oct-2023	Scientists reverse drug resistance in prostate cancer by targeting 'hijacked' white blood cells	The Institute of Cancer Research
17-Oct-2023	Amolyt Pharma Announces Data on Prevalence of Bone Disease in Patients with Hypoparathyroidism and Favorable Bone Effects of Eneboparatide at the American Society for Bone and Mineral Research (ASBMR) 2023 Annual Meeting	Amolyt Pharma
17-Oct-2023	Saama Signs New Agreement That Will Enable Artificial Intelligence-Driven Drug Development	Businesswire
17-Oct-2023	Gilead and Assembly Biosciences Establish Partnership to Develop Next-Generation Therapeutics for Serious Viral Diseases	Businesswire
17-Oct-2023	VedaBio Launches with Over $40 Million to Revolutionize Molecular Detection	Businesswire
17-Oct-2023	Theriva™ Biologics Announces Presentation at ESMO Congress 2023 Featuring Survival Outcomes in Phase 1 Study Evaluating VCN-01 in Combination with Durvalumab in Patients with Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck	Theriva™ Biologics, Inc
17-Oct-2023	Fighting Counterfeiting in the Medical and Pharmaceutical Industry: Origify offers End-to-End Authentication	Bosch
17-Oct-2023	PharmaKure announces study success for novel blood test to identify biomarkers in patients with Alzheimer’s Disease	PharmaKure
17-Oct-2023	New publication shows XF-73 drug potent against 2,527 Staphylococcus isolates Largest study of its kind to date demonstrates effectiveness of XF-73 against all tested antibiotic resistant strains	Destiny Pharma
17-Oct-2023	PureTech to Present at Two Upcoming Investor Conferences	PureTech Health
17-Oct-2023	Cell Line Engineering Breakthrough Cuts Drug Development Times by Up To 12 Months	Promega Corporation
17-Oct-2023	Global Advanced Wound Management Industry is likely to register an average CAGR of 3.6% Leading to US$11.5 Billion by 2033 \| FMI Insights	MARKITWIRED
17-Oct-2023	Moberg Pharma’s Nomination Committee appointed	Moberg Pharma
17-Oct-2023	Merck Receives Positive EU CHMP Opinion for PREVYMIS® for Prevention of CMV Disease in High-Risk Adult Kidney Transplant Recipients and Extended 200-Day Dosing in Adult HSCT Recipients at Risk for Late CMV Infection and Disease	Businesswire
17-Oct-2023	SpliceBio Enters Collaboration with Spark Therapeutics to Develop a Gene Therapy Targeting an Inherited Retinal Disease	SpliceBio
17-Oct-2023	Poolbeg Pharma Partners with a Nasdaq-Listed Biopharma Company on its Oral Delivery Platform	Poolbeg Pharma
17-Oct-2023	Recombinant Vaccines Industry Analysis, Future Prospects, and Regional Insights From 2018 To 2028 \| FMI Findings	MARKITWIRED
17-Oct-2023	Tessellate BIO Emerges from Stealth The Next Generation Synthetic Lethality Precision Oncology Company	Tessellate BIO
17-Oct-2023	Lytix Biopharma granted up to NOK14.3m (US$1.3m) of public non-dilutive funding from ’SkatteFUNN’	Lytix Biopharma
17-Oct-2023	STORM Therapeutics Presented Novel Pre-Clinical Data on STC-15 at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics	STORM Therapeutics Ltd